Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Upexi, Inc. (UPXI) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Upexi, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1775194.
Total stock buying since 2022: $4,575,185.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,156,170 | $3,239,470 | 0 | $0 | 0 | $0 |
| 2024 | 180,786 | $116,847 | 0 | $0 | 0 | $0 |
| 2023 | 328,058 | $596,387 | 0 | $0 | 0 | $0 |
| 2022 | 155,475 | $622,481 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 213,186 | $1,089,468 | 0 | $0 | 0 | $0 |
| 2025-04 | 942,984 | $2,150,002 | 0 | $0 | 0 | $0 |
| 2024-03 | 180,786 | $116,847 | 0 | $0 | 0 | $0 |
| 2023-12 | 156,391 | $137,952 | 0 | $0 | 0 | $0 |
| 2023-06 | 135,890 | $323,396 | 0 | $0 | 0 | $0 |
| 2023-05 | 22,776 | $77,734 | 0 | $0 | 0 | $0 |
| 2023-03 | 13,001 | $57,305 | 0 | $0 | 0 | $0 |
| 2022-12 | 30,475 | $122,481 | 0 | $0 | 0 | $0 |
| 2022-03 | 125,000 | $500,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-01 | Dugan Lawrence | Buy | 16,000 | 5.99 | 97,320 |
| 2025-07-01 | Salkind Gene | Buy | 20,243 | 4.94 | 100,000 |
| 2025-07-01 | Marshall Allan (Chief Executive Officer) | Buy | 161,943 | 4.94 | 799,998 |
| 2025-04-01 | Salkind Gene | Buy | 241,229 | 2.28 | 550,002 |
| 2025-04-01 | Norstrud Andrew James (Chief Financial Officer) | Buy | 43,860 | 2.28 | 100,000 |
| 2025-04-01 | Marshall Allan (Chief Executive Officer) | Buy | 657,895 | 2.28 | 1,500,000 |
| 2024-03-12 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 64,150 | .57 | 36,565 |
| 2024-03-11 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 13,623 | .60 | 8,173 |
| 2024-03-05 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 103,013 | .70 | 72,109 |
| 2023-12-15 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 4,535 | .91 | 4,126 |
| 2023-12-14 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 8,381 | .98 | 8,213 |
| 2023-12-07 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 90,001 | .94 | 84,960 |
| 2023-12-05 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 19,296 | .84 | 16,285 |
| 2023-12-04 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 34,178 | .71 | 24,368 |
| 2023-06-01 | Marshall Allan (Chief Executive Officer) | Buy | 79,945 | 2.37 | 188,782 |
| 2023-05-22 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 22,776 | 3.41 | 77,734 |
| 2023-03-17 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 4,095 | 4.41 | 18,075 |
| 2023-03-16 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 4,572 | 4.48 | 20,477 |
| 2023-03-15 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 4,334 | 4.33 | 18,753 |
| 2022-12-09 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 12,000 | 4.11 | 49,320 |
| 2022-12-01 | Marshall Allan (CHIEF EXECUTIVE OFFICER) | Buy | 18,475 | 3.96 | 73,161 |
| 2022-03-01 | Salkind Gene | Buy | 125,000 | 4.00 | 500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of UPXI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Upexi, Inc. (symbol UPXI, CIK number 1775194) see the Securities and Exchange Commission (SEC) website.